26 February 2026 - Melodia Therapeutics AG, a clinical-stage biotechnology company based in Switzerland, announced on Wednesday that the United States Patent and Trademark Office (USPTO) has granted a key a key patent covering a structurally novel DP...
26 February 2026 - Argo Biopharmaceutical Co Ltd, a China-based, clinical-stage small interfering RNA (siRNA) therapeutics company, announced on Wednesday that it has been selected as a late breaking abstract to present Phase II interim data for BW-2...
25 February 2026 - Life science research and diagnostics solutions provider Bruker Corporation (Nasdaq:BRKR) has introduced CellScape XR, a next-generation spatial proteomics platform designed to enhance diagnostic and prognostic assay development, t...
25 February 2026 - Pharmaceutical research services provider Charles River Laboratories International Inc (NYSE:CRL) announced on Wednesday that it has signed definitive agreements to sell its CDMO and Cell Solutions businesses to GI Partners, and ce...